In a report released today, Charles Rhyee from TD Cowen reiterated a Buy rating on GoodRx Holdings (GDRX – Research Report), with a price ...
TD Cowen analyst Tyler Van Buren maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of $1,030.00. The ...